Immunotherapy Study for Patients With Stage IV Melanoma
Clinical trial NCT02054520 · TERMINATED
Trial details
- NCT number
- NCT02054520
- Sponsor
- NewLink Genetics Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2018-04-05
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.